FDA's Science Board To Review Comparative Effectiveness, Pharmacovigilance, Nanotech
This article was originally published in The Pink Sheet Daily
Executive Summary
The May 20 meeting follows a recent reorganization of the safety functions in the Center for Drug Evaluation and Research.